España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Pliant Therapeutics
PLRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.00
-0.37
-2.57%
At close: -
$14.00
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Pliant Therapeutics (PLRX) Forecast
News
Earnings
Pliant Therapeutics (PLRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Pliant Therapeutics (NASDAQ:PLRX) Stock
Pliant Therapeutics Stock (NASDAQ: PLRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 13, 2024
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, November 18, 2024
Pliant Therapeutics Plans To Present Data Fro...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
Thursday, November 07, 2024
Pliant Therapeutics Q3 EPS $(0.95) Beats $(0....
Benzinga Newsdesk
Thursday, October 17, 2024
Pliant Therapeutics INTEGRIS-PSC Phase 2a Dat...
Benzinga Newsdesk
Friday, September 13, 2024
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Pliant Therapeutics Presents Data From Its Be...
Benzinga Newsdesk
Monday, September 09, 2024
Leerink Partners Assumes Pliant Therapeutics ...
Benzinga Newsdesk
Monday, August 26, 2024
Pliant Therapeutics Announces 4 Upcoming Pres...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Maintains Buy on Pliant T...
Benzinga Newsdesk
Thursday, August 08, 2024
Cantor Fitzgerald Reiterates Overweight on Pl...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Pliant Th...
Benzinga Newsdesk
Needham Reiterates Buy on Pliant Therapeutics...
Benzinga Newsdesk
Wednesday, August 07, 2024
Pliant Therapeutics Q2 EPS $(0.92) Misses $(0...
Benzinga Newsdesk
Tuesday, July 16, 2024
Needham Reiterates Buy on Pliant Therapeutics...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
Monday, July 15, 2024
Pliant Therapeutics Shares Long-Term Data Fro...
Benzinga Newsdesk
Friday, June 07, 2024
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
Thursday, June 06, 2024
Pliant Therapeutics To Present Data From Its ...
Benzinga Newsdesk
Wednesday, May 22, 2024
Reported Earlier, Pliant Therapeutics Present...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients
Vandana Singh
Pliant Therapeutics Announces Positive Toplin...
Benzinga Newsdesk
Tuesday, May 07, 2024
Citigroup Maintains Buy on Pliant Therapeutic...
Benzinga Newsdesk
These Analysts Revise Their Forecasts On Pliant Therapeutics Following Q1 Earnings
Avi Kapoor
RBC Capital Maintains Outperform on Pliant Th...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Pliant T...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Pliant Th...
Benzinga Newsdesk
Needham Reiterates Buy on Pliant Therapeutics...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
Monday, May 06, 2024
Pliant Therapeutics Q1 EPS $(0.78) Misses $(0...
Benzinga Newsdesk
Wednesday, April 10, 2024
Needham Reiterates Buy on Pliant Therapeutics...
Benzinga Newsdesk
Tuesday, March 12, 2024
Needham Reiterates Buy on Pliant Therapeutics...
Benzinga Newsdesk
Pliant Therapeutics Announces Accelerated Bex...
Benzinga Newsdesk
Tuesday, March 05, 2024
RBC Capital Maintains Outperform on Pliant Th...
Benzinga Newsdesk
Wednesday, February 28, 2024
HC Wainwright & Co. Reiterates Buy on Pliant ...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Pliant Th...
Benzinga Newsdesk
Needham Reiterates Buy on Pliant Therapeutics...
Benzinga Newsdesk
Tuesday, February 27, 2024
Pliant Therapeutics Q4 2023 GAAP EPS $(0.69) ...
Benzinga Newsdesk
Monday, February 05, 2024
Needham Maintains Buy on Pliant Therapeutics,...
Benzinga Newsdesk
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Why Is Liver Disease-Focused Pliant Therapeutics Stock Trading Lower Today?
Vandana Singh
HC Wainwright & Co. Maintains Buy Rating for Pliant Therapeutics: Here's What You Need To Know
Benzinga Insights
Pliant Therapeutics shares are trading lower ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Pliant T...
Benzinga Newsdesk
Sunday, February 04, 2024
Pliant Therapeutics Announced Bexotegrast 320 Mg PSC Phase 2a Trial Met Its Primary And Secondary Endpoints
Charles Gross
Friday, November 10, 2023
The Latest Analyst Ratings for Pliant Therapeutics
Benzinga Insights
RBC Capital Maintains Outperform on Pliant Th...
Benzinga Newsdesk
Thursday, November 09, 2023
Pliant Therapeutics Q3 EPS $(0.70) Beats $(0....
Benzinga Newsdesk
Monday, November 06, 2023
Pliant Therapeutics Presentations At The Annu...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch